News Endo gives way and withdraws opioid painkiller after FDA pre... Pharma makes decision after FDA intervenes to fight opioid crisis.
News UK ministers seek a soft Brexit for pharma Health and business secretaries commit to close working with EMA
News UK patients gain early access to Duchenne drug Patients to get Santhera's Raxone under EAMS scheme.
News Gottlieb outlines FDA digital health plan Plan aims to restructure regulation of new technologies.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
